Manchester Cancer Research Centre’s Post

PhD student Florentia Mousoullou from our Leukaemia Immunology & Transplantation group (https://lnkd.in/e8c_vj47) has put together a fantastic video review of the International PhD Student Conference (#IPSCC2024) which brings together cancer researchers from many different institutes for discussion, training and networking. If you're a new #PhD #student, check out this video for a great insight into what attending a conference is like 👇

Former Risk Comm Lab PhD student, and current postdoctoral fellow at the Johns Hopkins School of Medicine, Ariel Hoadley has had a first-authored paper, published! A big thank you to Linda Fleisher, PhD, MPH from the Fox Chase Cancer Center for all her help with this paper. Titled "Exploring Racial Disparities in Awareness and Perceptions of Oncology Clinical Trials: Cross-Sectional Analysis of Baseline Data From the mychoice Study," the paper is published in the Journal of Medical Internet Research. Read Here: https://lnkd.in/eSDFRP6U

NCI's Center for Cancer Research (CCR) is committed to supporting and training the next generation of scientists. Hear from CCR postdocs and investigators about what the Tenure-Track Investigator program is and how it can launch your career after graduation. https://go.nih.gov/9bRwNbL

Hi all- if you are a Spartan or know Spartan animal lovers, or Spartans working in the fight against cancer in the Bay Area, please share this today with your networks! We would love to have you join for our unique event this month on May 30th featuring our phenomenal faculty member Dr. Kurt Zinn. Dr. Zinn's innovative work is translational, connecting different fields of medicine. Find a snippet here from his Q and A with MSU Today: https://lnkd.in/e55GZrhb "Q: Which cancers are currently being studied through your biomedical research? A: We want to not just to kill the cancer, but to use it as a way to immunize the patient against the cancer. So, if cancer comes back in the future or if you don't get all of the cancer, you can still have a good prognosis. We currently have ongoing preclinical trials for ovarian cancer, plans for clinical trials for prostate cancer and will meet with the FDA soon to obtain guidance for conducting a funded clinical trial for bladder cancer using alpha-particle therapy."

Watch Wistar Science in Seconds, where researchers share their everyday work perspectives on foundational biomedical research. Here is Zhang lab postdoc Dr. Brennah Murphy on why she chose to dedicate herself to cancer research.

🎉 **Exciting News!** 🎉 I’m thrilled to share that I have officially passed my PhD dissertation in Cancer Biology! After years of hard work, dedication, and countless hours of research, I’ve reached this incredible milestone. My dissertation is titled "Molecular mechanisms governing osteosarcoma pulmonary metastasis" where I explored the molecular mechanisms behind the role of histone deacetylase inhibitors and neuropilin-1 (NRP1) in driving the metastatic spread of osteosarcoma to the lungs. This journey has been filled with challenges, growth, and many learning experiences. I’m deeply grateful to my mentor, committee members, peers, and loved ones for their support and encouragement throughout this process. A special thank you to my mentor, Conor Lynch, for his guidance, unwavering support, and for pushing me to be the best version of myself throughout this journey. As I celebrate this achievement, I’m also actively exploring new professional opportunities. With my expertise in molecular biology, I’m eager to contribute to cutting-edge research and innovation in biotech and pharmaceutical companies. I’m particularly interested in roles that focus on drug discovery, biomarker development, and therapeutic strategies. If you know of any opportunities or have advice in this space, I’d love to connect and discuss how my skills can add value to a dynamic team. The journey doesn’t end here—there’s always more to explore, create, and contribute. 🌱 Thank you to everyone who has been part of this journey. Here’s to new beginnings and the future ahead! 🚀 #PhD #CancerBiology #MolecularBiology #Biotech #Pharma #JobSearch #CareerTransition #NextChapter

I am happy to share that I have completed an introductory course on the Biology of Cancer from Johns Hopkins University. This course offers insights into the complexity of cancer mechanisms and the innovative approaches towards its treatment including ADCs. #CancerBiology #ADC

🎥🌟 This Thanksgiving, we’re celebrating by introducing some of our Churchill Scholars from the US! Watch as Theo Nelson, Maddie McCarthy, Alagu Subramanian and Sydney Hummel share what they are working on and reflect on some of their experiences thus far✨ Happy Thanksgiving to all celebrating today! 🦃🍂🥧 Cambridge Stem Cell Institute Cambridge Biomedical Campus Cancer Research UK Cambridge Institute Alagu Subramanian #Thanksgiving #ChurchillScholars #PublicPolicy #cancerresearchuk #Cambridge #CambridgeUniversity #postgradaute #postgraduatestudy

I am thrilled to share that I have completed the "Introduction to the Biology of Cancer" course offered by Johns Hopkins University. Excited to deepen my understanding of this critical field and contribute to advancing cancer research.🔬💊 #CancerBiology #ContinuousLearning

FEATURED MBoC ASSOCIATE EDITOR: Sandra Wolin, National Cancer Institute, National Institutes of Health How can MBoC benefit researchers in your area? “I believe that MBoC benefits our community by continuing to providing a home for high quality research in the broad area of cell biology. Like the society we represent, we strive to be a "big tent" in being inclusive and welcoming to researchers in every area of the very large discipline of cell biology. We also work to make sure that our colleagues' research is evaluated promptly, fairly and courteously.” https://lnkd.in/gKuGp-Bi